VTGN
USDVistagen Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$2.400
Максимум
$2.498
Минимум
$2.350
Объем
0.11M
Фундаментальные показатели компании
Рыночная капитализация
68.1M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.13M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
Company's PALISADE-4 Phase 3 trial now expected to read out in the first half of 2026 Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry
Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference
Posters Highlight New Insights into Social Anxiety Disorder and the Novel Mechanism of Action of Itruvone to Treat Major Depressive Disorder Vistagen (NASDAQ:VTGN), a clinical-stage biopharmaceutical company pioneering
Связанные акции
PFL
PIMCO Income Strategy Fund Shares of Beneficial Interest
INGR
Ingredion Incorporated
HIMS
Hims & Hers Health Inc.
LUXHP
LuxUrban Hotels Inc. 13.00% Series A Cumulative Redeemable Preferred Stock
XOMAP
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.